Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.36% slid 0.28% to $172.18 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.95% falling 0.02% to 4,400.64 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.00% falling 0.36% to 34,930.93. The stock's fall snapped a six-day winning streak. Johnson & Johnson closed $1.47 below its 52-week high ($173.65), which the company reached on January 26th.
The stock underperformed when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +2.27% fell 0.00% to $369.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.10% rose 0.62% to $78.33, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.07% rose 3.21% to $43.45. Trading volume (5.5 M) remained 845,760 below its 50-day average volume of 6.4 M.